Duncan Batty, Trustee




Duncan was awarded a Ph.D in Synthetic Organic Chemistry from University College London. Following Post-Doctoral Fellowships at the University of Illinois at Chicago and a CNRS ‘Poste Rouge’ at the Universite d’Orsay, Paris, he has spent most of his professional life in Pharmaceutical Research, working on a variety of disease conditions including cancer and pain.


Diagnosed with Alkaptonuria as a toddler, he has been receiving treatment for the effects of AKU since 1996 and has been prescribed nitisinone continuously since 2008. He has a younger brother with AKU and three older non-affected siblings.
Duncan has been associated with the AKU for over 10 yrs and is currently member of the TSC scientific advisory committee for the DevelopAKUre consortium.




AKU Twitter

AKU Blog

Looking forward to 2019
11-Jan-2019

Now we are all settled in after Christmas and the New Year, here at the AKU Society we would like.. ...more

2018 In Review
04-Jan-2019

A Happy New Year from Everyone at the AKU Society. Now that 2018 is well and truly behin.. ...more

DevelopAKUre SONIA 2 - Update
12-Dec-2018

We are happy to announce that two of our three SONIA 2 trial sites have now finished seeing patie.. ...more

Garrod Day Coffee Morning 2018 - On The Day
28-Nov-2018

Yesterday was the annual Garrod Day Coffee Morning. We celebrated Sir Archibald Garrod&.. ...more

Sir Archibald Garrod and Garrod Day 2018
01-Nov-2018

Garrod Day is quickly approaching. It’s a very important day in the history of alkapto.. ...more